JAZZJAZZ PHARMACEUTICALS PLC
CUSIP G50871105 · common stock
3 tracked investors held JAZZ PHARMACEUTICALS PLC (JAZZ) at the end of Q3 2026, worth $56.6M in total. The largest holder was Joel Greenblatt, with 0.1% of its portfolio. Perceptive Advisors sold out of its position this quarter.
Holders · Q3 2026
3
New holders
0
Value held
$56.6M
Quarter-end price (est.)
$231.52
Investors holding JAZZ · Q3 2026
| Investor | Weight | Shares | Value | Change |
|---|---|---|---|---|
| Joel Greenblatt Gotham Asset Management, LLC | 0.08% | 182,858 | $42.3M | ADD+63.2% |
| Tweedy Browne Tweedy, Browne Co LLC | 1.12% | 59,279 | $13.7M | REDUCE-1.4% |
| Polen Capital Management Polen Capital Management LLC | 0.01% | 2,125 | $492K | ADD+14.4% |
Sold out this quarter
| Investor | Prior weight | Prior shares | Prior value | Change |
|---|---|---|---|---|
| Perceptive Advisors | 0.61% | 170,000 | $41M | EXIT |
History
| Quarter | Holders | New | Sold out | Value held | Quarter-end price (est.) |
|---|---|---|---|---|---|
| Q3 2026 | 3 | 0 | 1 | $56.6M | $231.52 |
| Q2 2026 | 4 | 1 | 1 | $82.9M | $240.97 |
| Q1 2026 | 4 | 1 | 0 | $61.4M | $189.05 |
| Q4 2025 | 3 | 0 | 0 | $40.7M | $170.00 |
| Q3 2024 | 0 | 0 | 1 | $0 | — |
| Q2 2024 | 1 | 0 | 0 | $136M | $106.73 |
| Q1 2024 | 1 | 0 | 0 | $100.4M | $120.42 |
| Q4 2023 | 1 | 0 | 0 | $102.5M | $123.00 |
| Q3 2023 | 1 | 0 | 0 | $87.2M | $129.44 |
| Q2 2023 | 1 | 0 | 0 | $83.5M | $123.97 |
| Q1 2023 | 1 | 1 | 0 | $70M | $146.33 |